David Fajgenbaum is leading the study on repurposing drugs in order to treat coronavirus patients. (Photo from David Fajgenbaum)
David Fajgenbaum is leading the study on repurposing drugs in order to treat coronavirus patients. (Photo from David Fajgenbaum)